BAC
Bank of America Corporation
BAC's fundamentals are strong: its operating margin rose 5 points to 35% and revenue grew 15%. At 12x earnings, it's trading in line with its usual 13x. Analysts expect earnings growth.
EHTH
eHealth, Inc.
There isn't enough reported data to score EHTH yet.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
EHTH Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Stable | |
| N/A | |
| N/A |
EHTH's profitability is currently stable, but its revenue is weak. Free cash flow and net leverage aren't meaningful measures for financial services companies like EHTH.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
EHTH PE Valuation
EHTH has no meaningful PE right now: it lost money over the past year.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over EHTH on the outlook, with more favorable revenue expectations.
EHTH Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Decline | |
| Improving | |
| Limited | |
| High |
Analysts expect EHTH's earnings to grow and its profitability to improve, but its revenue to decline.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the stronger earnings trend. Trailing diluted EPS is up 14% for BAC versus EHTH down 150%.
EHTH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.82 | — |
| Q4 2024 | -$1.19 | +$1.18 |
| Q3 2024 | -$2.62 | +$0.78 |
| Q2 2024 | -$2.47 | +$0.97 |
| Q1 2024 | -$2.32 | +$1.59 |
| Q4 2023 | -$2.37 | +$1.99 |
| Q3 2023 | -$3.40 | +$2.89 |
| Q2 2023 | -$3.44 | +$3.37 |
| Q1 2023 | -$3.91 | +$2.11 |
EHTH is still losing money, but far less than before: $1.19 per share over the past year, against $6.81 at its worst in mid-2022.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over EHTH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over EHTH on profitability, with a higher operating margin.
EHTH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $21.3M | -60% |
| Q2 2026 | $33.6M | -45% |
| Q1 2026 | $88M | -22% |
| Q4 2025 | $326.2M | +3.5% |
| Q3 2025 | $53.9M | -7.8% |
| Q2 2025 | $60.8M | -7.7% |
| Q1 2025 | $113.1M | +22% |
| Q4 2024 | $315.2M | +27% |
EHTH's revenue is shrinking: $21M last quarter, down 60% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -218% | -141 points |
| Q2 2026 | -82% | -44 points |
| Q1 2026 | -3.3% | -7.5 points |
| Q4 2025 | 39% | +3 points |
| Q3 2025 | -77% | -3.1 points |
| Q2 2025 | -38% | +4.5 points |
| Q1 2025 | 4.2% | +24 points |
| Q4 2024 | 36% | +12 points |
EHTH's operating margin was −218% last quarter, down 141 points from the same quarter a year ago, near the bottom of its range since 2019.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC has the edge over EHTH on cash generation, producing positive trailing cash flow while its opponent burns cash.
EHTH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$11.3M | +$14.3M |
| Q2 2026 | -$5.4M | +$37.3M |
| Q1 2026 | $35.6M | -54% |
| Q4 2025 | -$36.1M | -$7.8M |
| Q3 2025 | -$25.5M | +$4.8M |
| Q2 2025 | -$42.8M | -$10.3M |
| Q1 2025 | $76.8M | +8.9% |
| Q4 2024 | -$28.3M | +$5.4M |
EHTH's free cash flow was −$17M over the past year, against −$20M the year before. Free cash flow isn't a meaningful measure for financial services companies like EHTH.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over EHTH on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
EHTH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.1% | +353K shares |
| 1 year | +5.7% | +1.7M shares |
| 3 years | +16% | +4.5M shares |
| 5 years | +21% | +5.5M shares |
| Available history | +31% | +7.6M shares |
EHTH has 32M diluted shares, up 5.7% from a year ago.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
EHTH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.1x | Healthy |
| Q2 2026 | 0.8x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.1x | Very low |
| Q2 2025 | 0.1x | Very low |
| Q1 2025 | -1.0x | Net Cash |
| Q4 2024 | 0.8x | Very low |
EHTH has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
EHTH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 22.2 | Oversold |
| Stochastic | 1.6 | Oversold |
EHTH's weekly RSI is 22 (oversold) and its Stochastic is 2 (oversold).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
EHTH PE vs Financial Services Sector
| Metric | EHTH | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
EHTH has no meaningful PE right now: it lost money over the past year.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has the edge over EHTH on trend strength, trading above more of its moving averages.
EHTH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.58 | 24% below |
| 20 week MA | $0.99 | 56% below |
| 50 week MA | $1.79 | 75% below |
| 100 week MA | $3.78 | 88% below |
| 200 week MA | $5.21 | 92% below |
EHTH is in a downtrend: it's below all five of its weekly moving averages, and 92% below its 200-week average.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has the edge over EHTH on returns for 2026, with the stronger performance.
EHTH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $94.4 | $73.9 | -22% |
| 2021 | $73.9 | $26.9 | -64% |
| 2022 | $26.9 | $4.43 | -84% |
| 2023 | $4.43 | $8.72 | +97% |
| 2024 | $8.72 | $8.65 | -0.8% |
| 2025 | $8.65 | $4.12 | -52% |
| 2026 YTD | $4.12 | $0.44 | -89% |
EHTH has finished lower in five of the last six years. It's down 89% so far in 2026.